Share
Print
Call Updates
Aug 8, 2022 10:18:03 AM
We recently informed the applicants about the evaluation results for their proposals submitted under this call. The results of the evaluation are as follows:
Apr 28, 2022 5:14:55 PM
Call HORIZON-HLTH-2022-IND-13 closed on 21 April 2022. 89 proposals were submitted.
The breakdown per topic is:
Evaluation results are expected to be communicated on Friday 5 August 2022 at the earliest.
Oct 6, 2021 12:00:01 AM
The submission session is now available for: HORIZON-HLTH-2022-IND-13-03(HORIZON-RIA)
New pricing and payment models for cost-effective and affordable health innovations
TOPIC ID: HORIZON-HLTH-2022-IND-13-03
Programme: Horizon Europe Framework Programme (HORIZON)
Call: A competitive health-related industry (2022) (HORIZON-HLTH-2022-IND-13)
Type of action: HORIZON-RIA HORIZON Research and Innovation Actions
Type of MGA: HORIZON Action Grant Budget-Based [HORIZON-AG]
Deadline model: single-stage
Planned opening date: 06 October 2021
Deadline date: 21 April 2022 17:00:00 Brussels time
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 6 “Maintaining an innovative, sustainable and globally competitive health industry”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:
Applicants are requested to propose new value-based pricing and reimbursement models that can help ensure equitable access to effective, efficient, affordable, and sustainable health technologies, including medicines, while supporting innovation and industrial competitiveness. The research should tackle the issue globally and be based on a multidisciplinary approach combining economic science, political science and sociology. The proposals should not be limited to the study of cost-effectiveness analyses and thresholds in decision-making. They should also address long term intended and unintended consequences of pricing and reimbursement decisions. Moreover, they should consider the potential limitation of no-coverage decision for products with high budgetary impact. Applicant consortia should include regulators and public entities that are in charge of attributing value tags to health technologies, negotiating with health technology manufacturers and/or reimbursing medical costs. Differences between public and private sectors could be considered, as appropriate. Proposals should also consider citizens engagement and dialogue, for seeking wider input and support, and could encourage other social innovation approaches.
Applicants should propose activities in all of the following areas:
Socio-economic science and humanities
Social Innovation